Safety and effectiveness of the sodium‐glucose cotransporter inhibitor bexagliflozin in cats newly diagnosed with diabetes mellitus

Abstract Background Bexagliflozin is a sodium‐glucose cotransporter 2 (SGLT2) inhibitor. A pilot study has shown that bexagliflozin can decrease dependence on exogenous insulin in cats with diabetes mellitus (DM). Objective To evaluate the safety and effectiveness of bexagliflozin as a monotherapy f...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Michael J. Hadd, Stephen E. Bienhoff, Susan E. Little, Samuel Geller, Jennifer Ogne‐Stevenson, Thomas J. Dupree, J. Catharine Scott‐Moncrieff
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Oxford University Press 2023-05-01
Rangatū:	Journal of Veterinary Internal Medicine
Ngā marau:	feline field study fructosamine half‐life hyperglycemia SGLT2
Urunga tuihono:	https://doi.org/10.1111/jvim.16730
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!